On the International Agency for Research on Cancer classification of glyphosate as a probable human carcinogen

被引:41
|
作者
Tarone, Robert E. [1 ,2 ]
机构
[1] US Natl Canc Inst, Rockville, MD USA
[2] Int Epidemiol Inst, Rockville, MD USA
关键词
carcinogen classification; glyphosate; International Agency for Research on Cancer; PRINCIPLES UNDERLYING SCIENCE; PESTICIDE USE; AGRICULTURAL HEALTH; EPIDEMIOLOGIC ENTERPRISE; PROSTATE-CANCER; RISK; PLEA; IARC; APPLICATORS; ADHERENCE;
D O I
10.1097/CEJ.0000000000000289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The recent classification by International Agency for Research on Cancer (IARC) of the herbicide glyphosate as a probable human carcinogen has generated considerable discussion. The classification is at variance with evaluations of the carcinogenic potential of glyphosate by several national and international regulatory bodies. The basis for the IARC classification is examined under the assumptions that the IARC criteria are reasonable and that the body of scientific studies determined by IARC staff to be relevant to the evaluation of glyphosate by the Monograph Working Group is sufficiently complete. It is shown that the classification of glyphosate as a probable human carcinogen was the result of a flawed and incomplete summary of the experimental evidence evaluated by the Working Group. Rational and effective cancer prevention activities depend on scientifically sound and unbiased assessments of the carcinogenic potential of suspected agents. Implications of the erroneous classification of glyphosate with respect to the IARC Monograph Working Group deliberative process are discussed.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 50 条
  • [41] The International Agency for Research on Cancer and e-cigarette carcinogenicity: time for an evaluation
    Braillon, Alain
    Lang, Adam Edward
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2023, 38 (04) : 391 - 391
  • [42] The International Agency for Research on Cancer and e-cigarette carcinogenicity: time for an evaluation
    Alain Braillon
    Adam Edward Lang
    European Journal of Epidemiology, 2023, 38 : 391 - 391
  • [43] Evaluation of cancer-preventive agents and strategies - A new program at the International Agency for Research on Cancer
    Vainio, H
    Bianchini, F
    CANCER PREVENTION: MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS, 2001, 952 : 177 - 180
  • [44] A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
    Rindi, Guido
    Klimstra, David S.
    Abedi-Ardekani, Behnoush
    Asa, Sylvia L.
    Bosman, Frederik T.
    Brambilla, Elisabeth
    Busam, Klaus J.
    de Krijger, Ronald R.
    Dietel, Manfred
    El-Naggar, Adel K.
    Fernandez-Cuesta, Lynnette
    Kloeppel, Guenter
    McCluggage, W. Glenn
    Moch, Holger
    Ohgaki, Hiroko
    Rakha, Emad A.
    Reed, Nicholas S.
    Rous, Brian A.
    Sasano, Hironobu
    Scarpa, Aldo
    Scoazec, Jean-Yves
    Travis, William D.
    Tallini, Giovanni
    Trouillas, Jacqueline
    van Krieken, J. Han
    Cree, Ian A.
    MODERN PATHOLOGY, 2018, 31 (12) : 1770 - 1786
  • [45] Agency costs in international human rights
    Moore, DH
    COLUMBIA JOURNAL OF TRANSNATIONAL LAW, 2004, 42 (02): : 491 - 519
  • [46] SPONSORSHIP OF POPULATION RESEARCH BY AGENCY FOR INTERNATIONAL DEVELOPMENT
    LIEBERMAN, MD
    POPULATION INDEX, 1969, 35 (03) : 224 - 224
  • [47] It is necessary to establish an International Agency for Research on Aging
    Anisimov, Vladimir N.
    Sidorenko, Alexandre V.
    AGING-US, 2018, 10 (05): : 863 - 867
  • [48] Risk Assessment of Chlorothalonil as a Probable Human Carcinogen on Selected Vegetables in an Eastern China Province
    Sun, Chen-Xi
    Liu, Bing
    Wang, Wen-Bo
    Yuan, Xue-Xia
    Wu, Yuan-Juan
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [49] Conflicts of interest in the International Agency for Research on Cancer process of identifying carcinogenic hazards to humans
    Elmore, Susan A.
    Berry, Colin
    Bolon, Brad
    Boorman, Gary A.
    Bradley, Alys E.
    Cohen, Samuel M.
    Klaunig, James E.
    Kluxen, Felix M.
    Maronpot, Robert R.
    Nyska, Abraham
    Papenfuss, Tracey L.
    Rehg, Jerold E.
    Resnik, David B.
    Rietjens, Ivonne M. C. M.
    Rosol, Thomas J.
    Suttie, Andrew W.
    Schoeb, Trenton R.
    Strupp, Christian
    Thoolen, Bob
    Weber, Klaus
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2025, 44
  • [50] Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program
    Goodman, Julie E.
    Mayfield, David B.
    Becker, Richard A.
    Hartigan, Suzanne B.
    Erraguntla, Neeraja K.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 113